Literature DB >> 6758408

Toxicity of different wheat gliadins in coeliac disease.

H Wieser, G Springer, H D Belitz, A Ashkenazi, D Idar.   

Abstract

To determine the toxic effect of different gliadins on coeliac patients, which has been variably assessed in the literature, wheat prolamines (gliadin) were separated into the main fractions alpha-, beta-, gamma-, and omega-gliadins by chromatography on Sulfopropyl Sephadex C-50. The chemical compositions of the gliands were characterized by polyacrylamide gel electrophoresis, amino-acid analysis, determination of amide nitrogen and peptide maps. The peptide fractions B2 and B3 were isolated from the gliadins by a peptic tryptic digestion, ultrafiltration and gel filtration on Sephadex G-50. The gliadins and the peptide fractions were examined for coeliac activity by immunological tests (LIF tests) and by organ-culture tests. The results show that the peptide fractions are generally more active than their respective gliadins. The peptide fractions of all gliadins have a coeliac-specific toxic effect; their activities correlate with the chemical composition of the gliadins.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6758408     DOI: 10.1007/bf01136247

Source DB:  PubMed          Journal:  Z Lebensm Unters Forsch        ISSN: 0044-3026


  3 in total

Review 1.  Organ culture of gastrointestinal mucosa--a technique for the study of the human gastrointestinal tract.

Authors:  P D Howdle
Journal:  Postgrad Med J       Date:  1984-10       Impact factor: 2.401

Review 2.  The immune recognition of gluten in coeliac disease.

Authors:  R Ciccocioppo; A Di Sabatino; G R Corazza
Journal:  Clin Exp Immunol       Date:  2005-06       Impact factor: 4.330

3.  Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients.

Authors:  K E Lundin; H Scott; T Hansen; G Paulsen; T S Halstensen; O Fausa; E Thorsby; L M Sollid
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.